[Granulomatous hepatitis following intravesical BCG immunotherapy for cancer of the bladder].
作者信息
Gargot D, Alexandre L, Sinico M, Salmeron S, Benoit G, Buffet C
出版信息
Gastroenterol Clin Biol. 1991;15(8-9):662-3.
PMID:1752384
Abstract
摘要
相似文献
1
[Granulomatous hepatitis following intravesical BCG immunotherapy for cancer of the bladder].
Gastroenterol Clin Biol. 1991;15(8-9):662-3.
2
BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer.BCG-RIVM：一种用于浅表性膀胱癌膀胱内免疫治疗的新型卡介苗制剂。
Chemioterapia. 1987 Jun;6(2 Suppl):713-6.
3
[Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report].[浅表性膀胱癌膀胱内卡介苗免疫治疗后肉芽肿性前列腺炎：一例报告]
Hinyokika Kiyo. 1990 Aug;36(8):953-5.
4
Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.膀胱癌初次膀胱内灌注卡介苗后发生分枝杆菌血症和肉芽肿性肝炎。
Am J Gastroenterol. 1993 Jul;88(7):1112-5.
5
BCG in bladder cancer.卡介苗与膀胱癌
Nurs Times. 1994;90(43):34-5.
6
Granulomatous hepatitis following intravesical BCG therapy.膀胱内卡介苗治疗后发生的肉芽肿性肝炎。
Br J Urol. 1990 Oct;66(4):432-3. doi: 10.1111/j.1464-410x.1990.tb14971.x.
7
Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy.并发肉芽肿性肝炎、肺炎和败血症作为膀胱内卡介苗免疫疗法的一种并发症。
BMJ Case Rep. 2013 Oct 10;2013:bcr2013200624. doi: 10.1136/bcr-2013-200624.
8
[Topical BCG therapy of in situ cancer of the urinary bladder].[膀胱原位癌的局部卡介苗治疗]
Urologe A. 1987 Jan;26(1):22-5.
9
Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.
Prog Clin Biol Res. 1989;303:383-91.
10
Intravesical BCG therapy in patients with superficial bladder tumors.浅表性膀胱肿瘤患者的膀胱内卡介苗治疗
Prog Clin Biol Res. 1989;310:153-60.
Zotero 插件